3-methylcholanthrene has been researched along with Compensatory Hyperinsulinemia in 1 studies
Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GLORGIO, I | 1 |
| BONOMO, GM | 1 |
| VAILATI, G | 1 |
1 other study available for 3-methylcholanthrene and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
[The influence of a condition of hyperinsulinism on the production of experimental tumors with 3-methylcholanthrene].
Topics: Animals; Hyperinsulinism; Leadership; Methylcholanthrene; Neoplasms; Neoplasms, Experimental | 1961 |